Pharma Co. Clarus Gets OK For Ch. 11 Drug Sale
A Delaware bankruptcy judge on Wednesday approved drug company Clarus Therapeutics' sale of its sole product for $7.25 million in cash and tens of millions in potential future royalties and payments....To view the full article, register now.
Already a subscriber? Click here to view full article